The identification and treatment of women with hyperglycaemia in pregnancy: An analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation

Health Technology Assessment

Volumn 20, Issue 86, 2016, Pages 1-382

  Farrar, Diane ^a,b   Simmonds, Mark ^b   Griffin, Susan ^b   Duarte, Ana ^b   Lawlor, Debbie A ^c   Sculpher, Mark ^b   Fairley, Lesley ^a   Golder, Su ^b   Tuffnell, Derek ^d   Bland, Martin ^b   Dunne, Fidelma ^e   Whitelaw, Donald ^d   Wright, John ^a   Sheldon, Trevor A ^b  

^a BRADFORD INSTITUTE FOR HEALTH RESEARCH   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d BRADFORD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; INSULIN; METFORMIN; ANTIDIABETIC AGENT;

ADVERSE OUTCOME; ARTICLE; BRITISH CITIZEN; CAUCASIAN; CHILDBIRTH; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DIABETIC DIET; DIAGNOSTIC TEST; DIET RESTRICTION; ECONOMIC EVALUATION; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HEALTH CARE POLICY; HIGH RISK PATIENT; HIGH RISK PREGNANCY; HUMAN; HYPERGLYCEMIA; LABORATORY TEST; LARGE FOR GESTATIONAL AGE; LOW RISK PATIENT; MEDICAL INFORMATION; META ANALYSIS; OBESITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREVALENCE; PROGENY; QUALITY ADJUSTED LIFE YEAR; REFERENCE VALUE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SOUTH ASIAN; SYSTEMATIC REVIEW; UNITED KINGDOM; ANALYSIS; DECISION TREE; DIET; ECONOMICS; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; MASS SCREENING; NATIONAL HEALTH SERVICE; PREGNANCY;

BLOOD GLUCOSE; COST-BENEFIT ANALYSIS; DECISION TREES; DIABETES, GESTATIONAL; DIET; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; MASS SCREENING; PREGNANCY; PREGNANCY OUTCOME; PREVALENCE; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; STATE MEDICINE; UNITED KINGDOM;

EID: 85006058967     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta20860     Document Type: Article

References (260)

1. Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Donovan L. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. Ann Intern Med 2013;159:123-9. http://dx.doi.org/10.7326/0003-4819-159-2-201307160-00661
2. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009;373:1773-9. http://dx.doi.org/10.1016/S0140-637609-60731-5
3. Shah BR, Retnakaran R, Booth GL. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care 2008;31:1668-9. http://dx.doi.org/10.2337/dc08-0706
4. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005;115:e290-6. http://dx.doi.org/10.1542/peds.2004-1808
5. Lawlor DA, Fraser A, Lindsay RS, Ness A, Dabelea D, Catalano P, et al. Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort. Diabetologia 2010;53:89-97. http://dx.doi.org/10.1007/s00125-009-1560-z
6. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991-2002. http://dx.doi.org/10.1056/NEJMoa0707943
7. Farrar D, Fairley L, Santorelli G, Tuffnell D, Sheldon TA, Wright J, et al. Association between hyperglycaemia and adverse perinatal outcomes in South Asian and white British women: analysis of data from the Born in Bradford cohort. Lancet Diabet Endocrinol 2015;3:795-804.
8. International Association of Diabetes and Pregnancy Study Groups Consensus panel. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care 2010;33:676-82. http://dx.doi.org/10.2337/dc09-1848
9. Nankervis A, McIntyre H, Moses R, Ross GP, Calloway L, Porter C, et al. ADIPS Consensus Guidelines for the Testing and Diagnosis of Gestational Diabetes Mellitus in Australia. 2013. URL: http://adips.org/downloads/ADIPSConsensusGuidelinesGDM-030513VersionACCEPTEDFINALpdf (accessed 3 September 2015).
10. World Health Organization (WHO). Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy. Geneva: WHO; 2013.
11. World Health Organization (WHO). Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: WHO; 1999.
12. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29(Suppl. 1):43-8.
13. Hoffman L, Nolan C, Wilson JD, Oats JJ, Simmons D. Gestational diabetes mellitus-management guidelines. The Australasian Diabetes in Pregnancy Society. Med J Aust 1998;169:93-7.
14. American College of Obstetricians and Gynecologists. Practice Bulletin Clinical Management Guidelines for Obstetricians-Gynecologists. Obstet Gynecol Clin North Am 2013;122:406-16.
15. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57. http://dx.doi.org/10.2337/diab.28.12.1039
16. O’Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964;13:278-85.
17. National Screening Committee. What is Screening? UK Screening Portal. URL: www.screening.nhs.uk/(accessed May 2015).
18. National Institute for Health and Care Excellence (NICE). Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal period. National Collaborating Centre for Women’s & Children’s Health (NCC-WCH). London: NICE; 2015.
19. National Collaborating Centre for Women’s & Children’s Health (NCC-WCH). Diabetes in Pregnancy. Management of Diabetes and Its Complications from Preconception to the Postnatal Period. London: NICE; 2015.
20. Catalano PM, Avallone DA, Drago NM, Amini SB. Reproducibility of the oral glucose tolerance test in pregnant women. Am J Obstet Gynecol 1993;169:874-81. http://dx.doi.org/10.1016/0002-9378(93)90019-F
21. Harlass FE, Brady K, Read JA. Reproducibility of the oral glucose tolerance test in pregnancy. Am J Obstet Gynecol 1991;164:564-8. http://dx.doi.org/10.1016/S0002-9378(11)80021-9
22. Wright J, Small N, Raynor P, Tuffnell D, Bhopal R, Cameron N. Cohort profile: the Born in Bradford multi-ethnic family cohort study. Int J Epidemiol 2012;4:1-14.
23. Lawlor DA, West J, Fairley L, Nelson SM, Bhopal RS, Tuffnell D, et al. Pregnancy glycaemia and cord-blood levels of insulin and leptin in Pakistani and white British mother-offspring pairs: findings from a prospective pregnancy cohort. Diabetologia 2014;57:2492-500. http://dx.doi.org/10.1007/s00125-014-3386-6
24. Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Donovan L. Diagnostic thresholds for gestational diabetes and their impact on pregnancy outcomes: a systematic review. Diabet Med 2014;31:319-31. http://dx.doi.org/10.1111/dme.12357
25. Jenum AK, Mørkrid K, Sletner L, Vangen S, Vange S, Torper JL, et al. Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study. Eur J Endocrinol 2012;166:317-24. http://dx.doi.org/10.1530/EJE-11-0866
26. Yajnik CS, Lubree HG, Rege SS, Naik SS, Deshpande JA, Deshpande SS, et al. Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocrinol Metab 2002;87:5575-80. http://dx.doi.org/10.1210/jc.2002-020434
27. West J, Lawlor DA, Fairley L, Bhopal R, Cameron N, McKinney PA, et al. UK-born Pakistani-origin infants are relatively more adipose than white British infants: findings from 8704 mother-offspring pairs in the Born-in-Bradford prospective birth cohort. J Epidemiol Community Health 2013;67:544-51. http://dx.doi.org/10.1136/jech-2012-201891
28. West J, Wright J, Fairley L, Sattar N, Whincup P, Lawlor DA. Do ethnic differences in cord blood leptin levels differ by birthweight category? Findings from the Born in Bradford cohort study. Int J Epidemiol 2014;43:249-54. http://dx.doi.org/10.1093/ije/dyt225
29. Yajnik CS, Joglekar CV, Lubree HG, Rege SS, Naik SS, Bhat DS, et al. Adiposity, inflammation and hyperglycaemia in rural and urban Indian men: Coronary Risk of Insulin Sensitivity in Indian Subjects (CRISIS) Study. Diabetologia 2008;51:39-46. http://dx.doi.org/10.1007/s00125-007-0847-1
30. Yajnik CS, Fall CH, Coyaji KJ, Hirve SS, Rao S, Barker DJ, et al. Neonatal anthropometry: the thin-fat Indian baby. The Pune Maternal Nutrition Study. Int J Obes Relat Metab Disord 2003;27:173-80. http://dx.doi.org/10.1038/sj.ijo.802219
31. Krishnaveni GV, Hill JC, Veena SR, Leary SD, Saperia J, Chachyamma KJ, et al. Truncal adiposity is present at birth and in early childhood in South Indian children. Indian Pediatr 2005;42:527-38.
32. Bansal N, Ayoola OO, Gemmell I, Vyas A, Koudsi A, Oldroyd J, et al. Effects of early growth on blood pressure of infants of British European and South Asian origin at one year of age: the Manchester children’s growth and vascular health study. J Hypertens 2008;26:412-18. http://dx.doi.org/10.1097/HJH.0b013e3282f3168e
33. National Institute for Health and Care Excellence (NICE). Caesarean Section. National Collaborating Centre for Women’s and Children’s Health. London: NICE; 2011.
34. Royal College of Paediatrics and Child Health (RCPCH). UK-WHO Growth Charts. 2014. URL: www.rcpch.ac.uk/improving-child-health/public-health/uk-who-growth-charts/uk-who-growthcharts-0-18-years (accessed 3 September 2015).
35. Wright CM, Williams AF, Elliman D, Bedford H, Birks E, Butler G, et al. Using the new UK-WHO growth charts. BMJ 2010;340:c1140. http://dx.doi.org/10.1136/bmj.c1140
36. HAPO Study Cooperative Research Group. The hyperglycaemia and adverse outcome (HAPO) study: associations with neonatal anthropometrics. Diabetes 2009;58:453-9. http://dx.doi.org/10.2337/db08-1112
37. West J, Manchester B, Wright J, Lawlor DA, Waiblinger D. Reliability of routine clinical measurements of neonatal circumferences and research measurements of neonatal skinfold thicknesses: findings from the Born in Bradford study. Paediatr Perinat Epidemiol 2011;25:164-71. http://dx.doi.org/10.1111/j.1365-3016.2010.01181.x
38. Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics 2000;56:645-6. http://dx.doi.org/10.1111/j.0006-341X.2000.00645.x
39. Office for National Statistics (ONS). Ethnic Group Statistics: A Guide for the Collection and Classification of Ethnicity Data. London: ONS: 2013. www.ethnic-group-statistics_tcm77-186499%20(2).pdf (accessed June 2015).
40. White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med 2011;30:377-99. http://dx.doi.org/10.1002/sim.4067
41. Pettitt DJ, McKenna S, McLaughlin C, Patterson CC, Hadden DR, McCance DR. Maternal glucose at 28 weeks of gestation is not associated with obesity in 2-year-old offspring: the Belfast Hyperglycemia and Adverse Pregnancy Outcome (HAPO) family study. Diabetes Care 2010;33:1219-23. http://dx.doi.org/10.2337/dc09-2384
42. Makgoba M, Savvidou MD, Steer PJ. An analysis of the interrelationship between maternal age, body mass index and racial origin in the development of gestational diabetes mellitus. BJOG 2012;119:276-82. http://dx.doi.org/10.1111/j.1471-0528.2011.03156.x
43. Mukerji G, Chiu M, Shah BR. Impact of gestational diabetes on the risk of diabetes following pregnancy among Chinese and South Asian women. Diabetologia 2012;55:2148-53. http://dx.doi.org/10.1007/s00125-012-2549-6
44. Dornhorst A, Paterson CM, Nicholls JS, Wadsworth J, Chiu DC, Elkeles RS, et al. High prevalence of gestational diabetes in women from ethnic minority groups. Diabet Med 1992;9:820-5. http://dx.doi.org/10.1111/j.1464-5491.1992.tb01900.x
45. Guariguata L, Linnenkamp U, Beagley J, Whiting DR, Cho NH. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract 2014;103:176-85. http://dx.doi.org/10.1016/j.diabres.2013.11.003
46. Holt RI, Coleman MA, McCance DR. The implications of the new International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria for gestational diabetes. Diabet Med 2011;28:382-5. http://dx.doi.org/10.1111/j.1464-5491.2011.03236.x
47. Moses RG. New consensus criteria for GDM: problem solved or a Pandora’s box? Diabetes Care 2010;33:690-1. http://dx.doi.org/10.2337/dc09-2306
48. Lawlor DA. The Society for Social Medicine John Pemberton Lecture 2011. Developmental overnutrition: an old hypothesis with new importance? Int J Epidemiol 2013;42:7-29. http://dx.doi.org/10.1093/ije/dys209
49. Lawlor DA, Relton C, Sattar N, Nelson SM. Maternal adiposity-a determinant of perinatal and offspring outcomes? Nat Rev Endocrinol 2012;8:679-88. http://dx.doi.org/10.1038/nrendo.2012.176
50. Donovan LE, Cundy T. Does exposure to hyperglycaemia in utero increase the risk of obesity and diabetes in the offspring? A critical reappraisal. Diabet Med 2015;32:295-304. http://dx.doi.org/10.1111/dme.12625
51. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS, Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477-86. http://dx.doi.org/10.1056/NEJMoa042973
52. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361:1339-48. http://dx.doi.org/10.1056/NEJMoa0902430
53. Meek CL, Lewis HB, Patient C, Murphy HR, Simmons D. Diagnosis of gestational diabetes mellitus: falling through the net. Diabetologia 2015;58:2003-12. http://dx.doi.org/10.1007/s00125-015-3647-z
54. Farrar D, Simmonds M, Bryant M, Sheldon TA, Tuffnell D, Golder S, et al. Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis. BMJ 2016;13:354.
55. Van Overveld L. Risk of Adverse Outcomes and the Association with Increases in Maternal Glucose Levels. Master’s thesis. Nijmegen: Radboud University; 2013.
56. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). PRISMA Statement. URL: www.prisma-statement.org (accessed June 2015).
57. Critical Appraisal Skills Programme (CASP). 2014. CASP Checklists. URL: www.casp-uk.net/#!casp-tools-checklists/c18f8 (accessed July 2014).
58. Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med 2013;158:280-6. http://dx.doi.org/10.7326/0003-4819-158-4-201302190-00009
59. Dunne F. Atlantic Diabetes in Pregnancy cohort. Personal communication. 2014.
60. Saravanan P. Warwick/Coventry individual participant data. Personal communication. 2013.
61. Landon MB, Mele L, Spong CY, Carpenter MW, Ramin SM, Casey B, et al. The relationship between maternal glycemia and perinatal outcome. Obstet Gynecol 2011;117:218-24. http://dx.doi.org/10.1097/AOG.0b013e318203ebe0
62. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88. http://dx.doi.org/10.1016/0197-2456(86)90046-2
63. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. http://dx.doi.org/10.1136/bmj.327.7414.557
64. Figueroa D, Landon MB, Mele L, Spong CY, Ramin SM, Casey B, et al. Relationship between 1-hour glucose challenge test results and perinatal outcomes. Obstet Gynecol 2013;121:1241-7. http://dx.doi.org/10.1097/AOG.0b013e31829277f5
65. Aris IM, Soh SE, Tint MT, Liang S, Chinnadurai A, Saw SM, et al. Effect of maternal glycemia on neonatal adiposity in a multiethnic Asian birth cohort. J Clin Endocrinol Metab 2014;99:240-7. http://dx.doi.org/10.1210/jc.2013-2738
66. Carr DB, Newton KM, Utzschneider KM, Faulenbach MV, Kahn SE, Easterling TR, Heckbert SR. Gestational diabetes or lesser degrees of glucose intolerance and risk of preeclampsia. Hypertens Pregnancy 2011;30:153-63. http://dx.doi.org/10.3109/10641950903115012
67. Chandna A, Zuberi LM, Munim S. Threshold values for the glucose challenge test in pregnancy. Int J Gynaecol Obstet 2006;94:119-20. http://dx.doi.org/10.1016/j.ijgo.2006.04.010
68. Cheng YW, McLaughlin GB, Esakoff TF, Block-Kurbisch I, Caughey AB. Glucose challenge test: screening threshold for gestational diabetes mellitus and associated outcomes. J Matern Fetal Neonatal Med 2007;20:903-8. http://dx.doi.org/10.1080/14767050701739384
69. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia. Am J Obstet Gynecol 2010;202:255.e1-7. http://dx.doi.org/10.1016/j.ajog.2010.01.024
70. Hillier TA, Pedula KL, Vesco KK, Schmidt MM, Mullen JA, LeBlanc ES, Pettitt DJ. Excess gestational weight gain: modifying fetal macrosomia risk associated with maternal glucose. Obstet Gynecol 2008;112:1007-14. http://dx.doi.org/10.1097/AOG.0b013e31818a9779
71. Jensen DM, Damm P, Sørensen B, Mølsted-Pedersen L, Westergaard JG, Klebe J, Beck-Nielsen H. Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol 2001;185:413-19. http://dx.doi.org/10.1067/mob.2001.115864
72. Kerényi Z, Tamás G, Kivimäki M, Péterfalvi A, Madarász E, Bosnyák Z, Tabák AG. Maternal glycemia and risk of large-for-gestational-age babies in a population-based screening. Diabetes Care 2009;32:2200-5. http://dx.doi.org/10.2337/dc09-1088
73. Lao TT, Ho LF. Does maternal glucose intolerance affect the length of gestation in singleton pregnancies? J Soc Gynecol Investig 2003;10:366-71. http://dx.doi.org/10.1016/S1071-5576(03)00115-1
74. Little RR, McKenzie EM, Shyken JM, Winkelmann SE, Ramsey LM, Madsen RW, Goldstein DE. Lack of relationship between glucose tolerance and complications of pregnancy in nondiabetic women. Diabetes Care 1990;13:483-7. http://dx.doi.org/10.2337/diacare.13.5.483
75. Lurie S, Levy R, Weiss R, Boultin G, Hagay ZJ. Low values on 50 gram glucose challenge test or oral 100 gram glucose tolerance test are associated with good perinatal outcome. J Obstet Gynaecol 1998;18:451-4. http://dx.doi.org/10.1080/01443619866778
76. Metzger BE, Persson B, Lowe LP, Dyer AR, Cruickshank JK, Deerochanawong C, et al. Hyperglycemia and adverse pregnancy outcome study: neonatal glycemia. Pediatrics 2010;126:e1545-52. http://dx.doi.org/10.1542/peds.2009-2257
77. Moses RG, Calvert D. Pregnancy outcomes in women without gestational diabetes mellitus related to the maternal glucose level. Is there a continuum of risk? Diabetes Care 1995;18:1527-33. http://dx.doi.org/10.2337/diacare.18.12.1527
78. Ong KK, Diderholm B, Salzano G, Wingate D, Hughes IA, MacDougall J, et al. Pregnancy insulin, glucose, and BMI contribute to birth outcomes in nondiabetic mothers. Diabetes Care 2008;31:2193-7. http://dx.doi.org/10.2337/dc08-1111
79. Pettitt DJ, Knowler WC, Baird HR, Bennett PH. Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians. Diabetes Care 1980;3:458-64. http://dx.doi.org/10.2337/diacare.3.3.458
80. Riskin-Mashiah S, Younes G, Damti A, Auslender R. First-trimester fasting hyperglycemia and adverse pregnancy outcomes. Diabetes Care 2009;32:1639-43. http://dx.doi.org/10.2337/dc09-0688
81. Savona-Ventura C, Craus J, Vella K, Grima S. Lowest threshold values for the 75g oral glucose tolerance test in pregnancy. Malta Med J 2010;22:18-20.
82. Scholl TO, Sowers M, Chen X, Lenders C. Maternal glucose concentration influences fetal growth, gestation, and pregnancy complications. Am J Epidemiol 2001;154:514-20. http://dx.doi.org/10.1093/aje/154.6.514
83. Sermer M, Naylor CD, Gare DJ, et al. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes: the Toronto tri-hospital gestational diabetes project. Am J Obstet Gynecol 1995;173:146-56. http://dx.doi.org/10.1016/0002-9378(95)90183-3
84. Subramaniam A, Jauk V, Tita A, Harper L. Interaction between maternal obesity and 1-hour glucose challenge test results on maternal and perinatal outcomes. Am J Obs Gynecol 2014;210:S132. http://dx.doi.org/10.1016/j.ajog.2013.10.279
85. Tallarigo L, Giampietro O, Penno G, Miccoli R, Gregori G, Navalesi R. Relation of glucose tolerance to complications of pregnancy in nondiabetic women. N Engl J Med 1986;315:989-92. http://dx.doi.org/10.1056/NEJM198610163151603
86. Witter FR, Niebyl JR. Abnormal glucose screening in pregnancy in patients with normal oral glucose tolerance tests as a screening test for fetal macrosomia. Int J Gynaecol Obstet 1988;27:181-4. http://dx.doi.org/10.1016/0020-7292(88)90005-7
87. Yee LM, Cheng YW, Liddell J, Block-Kurbisch I, Caughey AB. 50-Gram glucose challenge test: is it indicative of outcomes in women without gestational diabetes mellitus? J Matern Fetal Neonatal Med 2011;24:1102-6. http://dx.doi.org/10.3109/14767058.2010.546450
88. Aberg A, Rydhstroem H, Frid A. Impaired glucose tolerance associated with adverse pregnancy outcome: a population-based study in southern Sweden. Am J Obstet Gynecol 2001;184:77-83. http://dx.doi.org/10.1067/mob.2001.108085
89. Dudhbhai M, Lim L, Bombard A, Juliard K, Meenakshi B, Trachelenberg Y, Weiner Z. Characteristics of patients with abnormal glucose challenge test and normal oral glucose tolerance test results: comparison with normal and gestational diabetic patients. Am J Obstet Gynecol 2006;194:e42-5. http://dx.doi.org/10.1016/j.ajog.2005.11.031
90. Forest JC, Massé J, Garrido-Russo M. Glucose tolerance test during pregnancy: the significance of one abnormal value. Clin Biochem 1994;27:299-304. http://dx.doi.org/10.1016/0009-9120(94)00029-8
91. Hedderson MM, Ferrara A, Sacks DA. Gestational diabetes mellitus and lesser degrees of pregnancy hyperglycemia: association with increased risk of spontaneous preterm birth. Obstet Gynecol 2003;102:850-6. http://dx.doi.org/10.1097/00006250-200310000-00030
92. Herman G, Raimondi B. Glucose tolerance, fetal growth, and pregnancy complications in normal women. Am J Perinatol 1988;5:168-71. http://dx.doi.org/10.1055/s-2007-999679
93. Jiménez-Moleón JJ, Bueno-Cavanillas A, Luna-Del-Castillo JD, Garciá-Martín M, Lardelli-Claret P, Gálvez-Vargas R. Prevalence of gestational diabetes mellitus: variations related to screening strategy used. Eur J Endocrinol 2002;146:831-7. http://dx.doi.org/10.1530/eje.0.1460831
94. Khoshniat Nikoo M, Garshasbi A, Amini S, Pasandi F, Peimani M, Larijani B. Relationship between maternal glucose intolerance and fasting plasma glucose with macrosomia during pregnancy. Iran J Diabet Lipid Disorders 2010;9:1-7.
95. Langer O, Yogev Y, Most O, Xenakis EM. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol 2005;192:989-97. http://dx.doi.org/10.1016/j.ajog.2004.11.039
96. Lapolla A, Dalfrà MG, Bonomo M, Castiglioni MT, Di Cianni G, Masin M, et al. Can plasma glucose and HbA1c predict fetal growth in mothers with different glucose tolerance levels? Diabetes Res Clin Pract 2007;77:465-70. http://dx.doi.org/10.1016/j.diabres.2007.01.022
97. Ma KK, Mele L, Landon MB, Spong CY, Ramin SM, Casey B, et al. The obstetric and neonatal implications of a low value on the 50-g glucose screening test. Am J Perinatol 2013;30:715-22. http://dx.doi.org/10.1055/s-0032-1331027
98. Naylor CD, Sermer M, Chen E, Sykora K. Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? Toronto Trihospital Gestational Diabetes Investigators. JAMA 1996;275:1165-70. http://dx.doi.org/10.1001/jama.1996.03530390031030
99. Nord E, Hanson U, Persson B. Blood glucose limits in the diagnosis of impaired glucose tolerance during pregnancy. Relation to morbidity. Acta Obstet Gynecol Scand 1995;74:589-93. http://dx.doi.org/10.3109/00016349509013467
100. Özekinci M, Mendilcioglu I, Inel M, Simsek M, Gülkesen KH. Abnormal one-hour 50-gram glucose challenge test and perinatal outcomes. Turkiye Klinikleri J Med Sci 2011;31:1211-17. http://dx.doi.org/10.5336/medsci.2010-21971
101. Pugh SK, Poole AT, Hill JB, Magann EF, Chauhan SP, Morrison JC. Abnormal 1 hour glucose challenge test followed by a normal 3 hour glucose tolerance test: does it identify adverse pregnancy outcome? J Miss State Med Assoc 2010;51:3-6.
102. Retnakaran R, Qi Y, Sermer M, Connelly PW, Zinman B, Hanley AJ. Isolated hyperglycemia at 1 hour on oral glucose tolerance test in pregnancy resembles gestational diabetes mellitus in predicting postpartum metabolic dysfunction. Diabetes Care 2008;31:1275-81. http://dx.doi.org/10.2337/dc08-0126
103. Stamilio DM, Olsen T, Ratcliffe S, Sehdev HM, Macones GA. False-positive 1-hour glucose challenge test and adverse perinatal outcomes. Obstet Gynecol 2004;103:148-56. http://dx.doi.org/10.1097/01.AOG.0000109220.24211.BD
104. Tarim E, Cok T. Macrosomia prediction using different maternal and fetal parameters in women with 50 g glucose challenge test between 130 and 140 mg/dl. Arch Gynecol Obstet 2011;284:1081-5. http://dx.doi.org/10.1007/s00404-010-1797-2
105. Vambergue A, Nuttens MC, Verier-Mine O, Dognin C, Cappoen JP, Fontaine P. Is mild gestational hyperglycaemia associated with maternal and neonatal complications? The Diagest Study. Diabet Med 2000;17:203-8. http://dx.doi.org/10.1046/j.1464-5491.2000.00237.x
106. Wang P, Lu MC, Yan YH. Abnormal glucose tolerance is associated with preterm labor and increased neonatal complications in Taiwanese women. Taiwan J Obstet Gynecol 2013;52:479-84. http://dx.doi.org/10.1016/j.tjog.2013.10.005
107. Yogev Y, Langer O, Xenakis EM, Rosenn B. The association between glucose challenge test, obesity and pregnancy outcome in 6390 non-diabetic women. J Matern Fetal Neonatal Med 2005;17:29-34. http://dx.doi.org/10.1080/14767050400028766
108. Hillier TA, Pedula KL, Schmidt MM, Mullen JA, Charles MA, Pettitt DJ. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care 2007;30:2287-92. http://dx.doi.org/10.2337/dc06-2361
109. Pettitt DJ, Bennett PH, Saad MF, Charles MA, Nelson RG, Knowler WC. Abnormal glucose tolerance during pregnancy in Pima Indian women. Long-term effects on offspring. Diabetes 1991;40(Suppl. 2):126-30. http://dx.doi.org/10.2337/diab.40.2.S126
110. Black MH, Sacks DA, Xiang AH, Lawrence JM. Clinical outcomes of pregnancies complicated by mild gestational diabetes mellitus differ by combinations of abnormal oral glucose tolerance test values. Diabetes Care 2010;33:2524-30. http://dx.doi.org/10.2337/dc10-1445
111. Franks PW, Looker HC, Kobes S, Touger L, Tataranni PA, Hanson RL, Knowler WC. Gestational glucose tolerance and risk of type 2 diabetes in young Pima Indian offspring. Diabetes 2006;55:460-5. http://dx.doi.org/10.2337/diabetes.55.02.06.db05-0823
112. Jensen DM, Korsholm L, Ovesen P, Beck-Nielsen H, Mølsted-Pedersen L, Damm P. Adverse pregnancy outcome in women with mild glucose intolerance: is there a clinically meaningful threshold value for glucose? Acta Obstet Gynecol Scand 2008;87:59-62. http://dx.doi.org/10.1080/00016340701823975
113. Kim HS, Chang KH, Yang JI, Yang SC, Lee HJ, Ryu HS. Clinical outcomes of pregnancy with one elevated glucose tolerance test value. Int J Gynaecol Obstet 2002;78:131-8. http://dx.doi.org/10.1016/S0020-7292(02)00129-7
114. Khan KS, Syed AH, Hashmi FA, Rizvi JH. Relationship of fetal macrosomia to a 75g glucose challenge test in nondiabetic pregnant women. Aust N Z J Obstet Gynaecol 1994;34:24-7. http://dx.doi.org/10.1111/j.1479-828X.1994.tb01033.x
115. Atia HC, Koren Y, Weintraub AY, Novack L, Sheiner E. Is a value of over 200 mg/dL in the oral glucose tolerance test, a marker of severity in patients with gestational diabetes mellitus? J Matern Fetal Neonatal Med 2013;26:1259-62. http://dx.doi.org/10.3109/14767058.2013.777421
116. Koyanagi A, Zhang J, Dagvadorj A, Hirayama F, Shibuya K, Souza JP, Gülmezoglu AM. Macrosomia in 23 developing countries: an analysis of a multicountry, facility-based, crosssectional survey. Lancet 2013;381:476-83. http://dx.doi.org/10.1016/S0140-673612-61605-5
117. Retnakaran R, Hanley AJ, Connelly PW, Sermer M, Zinman B. Ethnicity modifies the effect of obesity on insulin resistance in pregnancy: a comparison of Asian, South Asian, and Caucasian women. J Clin Endocrinol Metab 2006;91:93-7. http://dx.doi.org/10.1210/jc.2005-1253
118. Koukkou E, Taub N, Jackson P, Metcalfe G, Cameron M, Lowy C. Difference in prevalence of gestational diabetes and perinatal outcome in an innercity multiethnic London population. Eur J Obstet Gynecol Reprod Biol 1995;59:153-7. http://dx.doi.org/10.1016/0028-2243(95)02043-R
119. Bryant M, Santorelli G, Lawlor DA, Farrar D, Tuffnell D, Bhopal R, Wright J. A comparison of South Asian specific and established BMI thresholds for determining obesity prevalence in pregnancy and predicting pregnancy complications: findings from the Born in Bradford cohort. Int J Obes 2014;38:444-50. http://dx.doi.org/10.1038/ijo.2013.117
120. Chu SY, Callaghan WM, Kim SY, Schmid CH, Lau J, England LJ, Dietz PM. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care 2007;30:2070-6. http://dx.doi.org/10.2337/dc06-2559a
121. Cundy T. Proposed new diagnostic criteria for gestational diabetes: a pause for thought? Diabet Med 2012;29:176-80.
122. Avalos GE, Owens LA, Dunne F, ATLANTIC DIP Collaborators. Applying current screening tools for gestational diabetes mellitus to a European population: is it time for change? Diabetes Care 2013;36:3040-4. http://dx.doi.org/10.2337/dc12-2669
123. Strong M, Oakley J, Brennan A. Estimating multi-parameter partial Expected Value of Perfect Information from a probabilistic sensitivity analysis sample: a non-parametric regression approach. Med Decis Making 2014;34:311-26. http://dx.doi.org/10.1177/0272989X13505910
124. Farrar D, Fairley L, Wright J, Tuffnell D, Whitelaw D, Lawlor DA. Evaluation of the impact of universal testing for gestational diabetes mellitus on maternal and neonatal health outcomes: a retrospective analysis. BMC Pregnancy Childbirth 2014;14:317. http://dx.doi.org/10.1186/1471-2393-14-317
125. Di Cianni G, Miccoli R, Volpe L, Lencioni C, Del Prato S. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev 2003;19:259-70. http://dx.doi.org/10.1002/dmrr.390
126. Ali FM, Farah N, O’Dwyer V, O’Connor C, Kennelly MM, Turner MJ. The impact of new national guidelines on screening for gestational diabetes mellitus. Ir Med J 2013;106:57-9.
127. Gregory R, Swinn RA, Wareham N, Curling V, Dalton KJ, Edwards OM, O’Rahilly S. An audit of a comprehensive screening programme for diabetes in pregnancy. Pract Diabetes Int 1998;15:45-8. http://dx.doi.org/10.1002/pdi.1960150208
128. Janghorbani M, Stenhouse E, Jones RB, Millward A. Gestational diabetes mellitus in Plymouth, U.K.: prevalence, seasonal variation and associated factors. J Reprod Med 2006;51:128-34.
129. Khalifeh A, Breathnach F, Coulter-Smith S, Robson M, Fitzpatrick C, Malone F. Changing trends in diabetes mellitus in pregnancy. J Obstet Gynaecol 2014;34:135-7. http://dx.doi.org/10.3109/01443615.2013.830596
130. O’Sullivan EP, Avalos G, O’Reilly M, Dennedy MC, Gaffney G, Dunne FP, Atlantic DIP collaborators. Atlantic DIP: the prevalence and consequences of gestational diabetes in Ireland. Ir Med J 2012;105(Suppl. 5):13-15.
131. Sacks DA, Hadden DR, Maresh M, Deerochanawong C, Dyer AR, Metzger BE, et al. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 2012;35:526-8. http://dx.doi.org/10.2337/dc11-1641
132. Samanta A, Burden ML, Burden AC, Jones GR. Glucose tolerance during pregnancy in Asian women. Diabetes Res Clin Pract 1989;7:127-35. http://dx.doi.org/10.1016/0168-8227(89)90103-4
133. Griffin ME, Coffey M, Johnson H, Scanlon P, Foley M, Stronge J, et al. Universal vs. risk factor-based screening for gestational diabetes mellitus: detection rates, gestation at diagnosis and outcome. Diabet Med 2000;17:26-32. http://dx.doi.org/10.1046/j.1464-5491.2000.00214.x
134. Jolly M, Sebire N, Harris J, Robinson S, Regan L. The risks associated with pregnancy in women aged 35 years or older. Hum Reprod Update 2000;15:2433-7. http://dx.doi.org/10.1093/humrep/15.11.2433
135. O’Sullivan EP, Avalos G, O’Reilly M, Dennedy MC, Gaffney G, Dunne F. Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria. Diabetologia 2011;54:1670-5. http://dx.doi.org/10.1007/s00125-011-2150-4
136. American Diabetes Association (ADA). Standards of medical care in diabetes-2014. Diabetes Care 2014;37(Suppl. 1):14-80. http://dx.doi.org/10.2337/dc14-s014
137. Gillespie P, O’Neill C, Avalos G, O’Reilly M, Dunne F, ATLANTIC DIP Collaborators. The cost of universal screening for gestational diabetes mellitus in Ireland. Diabet Med 2011;28:912-18. http://dx.doi.org/10.1111/j.1464-5491.2011.03293.x
138. Simmonds MC, Wald NJ. Risk estimation versus screening performance: a comparison of six risk algorithms for cardiovascular disease. J Med Screen 2012;19:201-5. http://dx.doi.org/10.1258/jms.2012.012076
139. Yang X, Hsu-Hage B, Yu L, Simmons D. Selective screening for gestational diabetes in Chinese women. Diabetes Care 2002;25:796. http://dx.doi.org/10.2337/diacare.25.4.796
140. Van Leeuwen M, Opmeer BC, Zweers EJ, van Ballegooie E, ter Brugge HG, de Valk HW, et al. External validation of a clinical scoring system for the risk of gestational diabetes mellitus. Diabetes Res Clin Pract 2009;85:96-101. http://dx.doi.org/10.1016/j.diabres.2009.04.025
141. Van Leeuwen M, Opmeer BC, Zweers EJ, van Ballegooie E, ter Brugge HG, de Valk HW, et al. Estimating the risk of gestational diabetes mellitus: a clinical prediction model based on patient characteristics and medical history. BJOG 2010;117:69-75. http://dx.doi.org/10.1111/j.1471-0528.2009.02425.x
142. Caliskan E, Kayikcioglu F, Oztürk N, Koc S, Haberal A. A population-based risk factor scoring will decrease unnecessary testing for the diagnosis of gestational diabetes mellitus. Acta Obstet Gynecol Scand 2004;83:524-30. http://dx.doi.org/10.1111/j.0001-6349.2004.00389.x
143. Cosson E, Benbara A, Pharisien I, Nguyen MT, Revaux A, Lormeau B, et al. Diagnostic and prognostic performances over 9 years of a selective screening strategy for gestational diabetes mellitus in a cohort of 18,775 subjects. Diabetes Care 2013;36:598-603. http://dx.doi.org/10.2337/dc12-1428
144. Cypryk K, Szymczak W, Czupryniak L, Sobczak M, Lewinski A. Gestational diabetes mellitus: an analysis of risk factors. Endokrynol Pol 2008;59:393-7.
145. Jensen DM, Mølsted-Pedersen L, Beck-Nielsen H, Westergaard JG, Ovesen P, Damm P. Screening for gestational diabetes mellitus by a model based on risk indicators: a prospective study. Am J Obstet Gynecol 2003;189:1383-8. http://dx.doi.org/10.1067/S0002-9378(03)00601-X
146. Danilenko-Dixon DR, Van Winter JT, Nelson RL, Ogburn PL. Universal versus selective gestational diabetes screening: application of 1997 American Diabetes Association recommendations. Am J Obstet Gynecol 1999;181:798-802. http://dx.doi.org/10.1016/S0002-9378(99)70304-2
147. Marquette GP, Klein VR, Niebyl JR. Efficacy of screening for gestational diabetes. Am J Perinatol 1985;2:7-9. http://dx.doi.org/10.1055/s-2007-999901
148. Moses RG, Moses J, Davis WS. Gestational diabetes: do lean young Caucasian women need to be tested? Diabetes Care 1998;21:1803-6. http://dx.doi.org/10.2337/diacare.21.11.1803
149. Nanda S, Savvidou M, Syngelaki A, Akolekar R, Nicolaides KH. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn 2011;31:135-41. http://dx.doi.org/10.1002/pd.2636
150. Ostlund I, Hanson U. Occurrence of gestational diabetes mellitus and the value of different screening indicators for the oral glucose tolerance test. Acta Obstet Gynecol Scand 2003;82:103-8. http://dx.doi.org/10.1080/j.1600-0412.2003.00001.x
151. Phaloprakarn C, Tangjitgamol S, Manusirivithaya S. A risk score for selective screening for gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol 2009;145:71-5. http://dx.doi.org/10.1016/j.ejogrb.2009.04.016
152. Pintaudi B, Di Vieste G, Corrado F, Lucisano G, Pellegrini F, Giunta L, et al. Improvement of selective screening strategy for gestational diabetes through a more accurate definition of high-risk groups. Eur J Endocrinol 2014;170:87-93. http://dx.doi.org/10.1530/EJE-13-0759
153. Sacks DA, Abu-Fadil S, Karten GJ, Forsythe AB, Hackett JR. Screening for gestational diabetes with the one-hour 50-g glucose test. Obstet Gynecol 1987;70:89-93.
154. Shamsuddin K, Mahdy ZA, Siti Rafiaah I, Jamil MA, Rahimah MD. Risk factor screening for abnormal glucose tolerance in pregnancy. Int J Gynaecol Obstet 2001;75:27-32. http://dx.doi.org/10.1016/S0020-7292(01)00468-4
155. Shirazian N, Emdadi R, Mahboubi M, Motevallian A, Fazel-Sarjuei Z, Sedighpour N, et al. Screening for gestational diabetes: usefulness of clinical risk factors. Arch Gynecol Obstet 2009;280:933-7. http://dx.doi.org/10.1007/s00404-009-1027-y
156. Sunsaneevithayakul P, Boriboohirunsarn D, Sutanthavibul A, Ruangvutilert P, Kanokpongsakdi S, Singkiratana D, Bunyawanichkul S. Risk factor-based selective screening program for gestational diabetes mellitus in Siriraj Hospital: result from clinical practice guideline. J Med Assoc Thai 2003;86:708-14.
157. Teh WT, Teede HJ, Paul E, Harrison CL, Wallace EM, Allan C. Risk factors for gestational diabetes mellitus: implications for the application of screening guidelines. Aust N Z J Obstet Gynaecol 2011;51:26-30. http://dx.doi.org/10.1111/j.1479-828X.2011.01292.x
158. Williams CB, Iqbal S, Zawacki CM, Yu D, Brown MB, Herman WH. Effect of selective screening for gestational diabetes. Diabetes Care 1999;22:418-21. http://dx.doi.org/10.2337/diacare.22.3.418
159. Corcoy R, García-Patterson A, Pau E, Pascual E, Altirriba O, Adelantado JM, de Leiva A. Is selective screening for gestational diabetes mellitus worthwhile everywhere? Acta Diabetol 2004;41:154-7. http://dx.doi.org/10.1007/s00592-004-0159-6
160. Crete JE, Anasti JN. Diagnosis of gestational diabetes mellitus: can we avoid the glucose challenge test? J Am Assoc Nurse Pract 2013;25:329-33. http://dx.doi.org/10.1111/j.1745-7599.2012.00792.x
161. Davey RX, Hamblin PS. Selective versus universal screening for gestational diabetes mellitus: an evaluation of predictive risk factors. Med J Aust 2001;174:118-21.
162. Göbl CS, Bozkurt L, Rivic P, Schernthaner G, Weitgasser R, Pacini G, et al. A two-step screening algorithm including fasting plasma glucose measurement and a risk estimation model is an accurate strategy for detecting gestational diabetes mellitus. Diabetologia 2012;55:3173-81. http://dx.doi.org/10.1007/s00125-012-2726-7
163. Cosson E, Benchimol M, Carbillon L, Pharisien I, Pariès J, Valensi P, et al. Universal rather than selective screening for gestational diabetes mellitus may improve fetal outcomes. Diabet Metab 2006;32:140-6. http://dx.doi.org/10.1016/S1262-3636(07)70260-4
164. Naylor CD, Sermer M, Chen E, Farine D. Selective screening for gestational diabetes mellitus. Toronto Trihospital Gestational Diabetes Project Investigators. N Engl J Med 1997;337:1591-6. http://dx.doi.org/10.1056/NEJM199711273372204
165. Savona-Ventura C, Vassallo J, Marre M, Karamanos BG, MGSD-GDM study group. A composite risk assessment model to screen for gestational diabetes mellitus among Mediterranean women. Int J Gynaecol Obstet 2013;120:240-4. http://dx.doi.org/10.1016/j.ijgo.2012.10.016
166. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768-73. http://dx.doi.org/10.1016/0002-9378(82)90349-0
167. Seghieri G, De Bellis A, Anichini R, Alviggi L, Franconi F, Breschi MC. Does parity increase insulin resistance during pregnancy? Diabet Med 2005;22:1574-80. http://dx.doi.org/10.1111/j.1464-5491.2005.01693.x
168. Alwan N, Tuffnell D, West J. Treatments for gestational diabetes. Cochrane Database Syst Rev 2009;3: CD003395. http://dx.doi.org/10.1002/14651858.cd003395.pub2
169. Horvath K, Koch K, Jeitler K, Matyas E, Bender R, Bastian H, et al. Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis. BMJ 2010;340:c1395. http://dx.doi.org/10.1136/bmj.c1395
170. Falavigna M, Prestes I, Schmidt MI, Duncan BB, Colagiuri S, Roglic G. Impact of gestational diabetes mellitus screening strategies on perinatal outcomes: a simulation study. Diabetes Res Clin Pract 2013;99:358-65. http://dx.doi.org/10.1016/j.diabres.2012.12.009
171. Gui J, Liu Q, Feng L. Metformin vs insulin in the management of gestational diabetes: a meta-analysis. PLOS ONE 2013;8:e64585. http://dx.doi.org/10.1371/journal.pone.0064585
172. The Cochrane Collaboration. The Cochrane Collaboration’s Tool for Assessing Risk of Bias. URL: http://ohgcochrane.org/sites/ohgcochraneorg/files/uploads/Risk%20of%20bias%20assessment%20tool.pdf (accessed January 2014).
173. Bafeta A, Trinquart L, Seror R, Ravaud P. Reporting of results from network meta-analyses: methodological systematic review. BMJ 2014;348:g1741. http://dx.doi.org/10.1136/bmj.g1741
174. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004;23:3105-24. http://dx.doi.org/10.1002/sim.1875
175. Hassan JA, Karim N, Sheikh Z. Metformin prevents macrosomia and neonatal morbidity in gestational diabetes. Pak J Med Sci 2012;28:384-9.
176. Hague WM, Davoren PM, Oliver J, Rowan J. Contraindications to use of metformin. Metformin may be useful in gestational diabetes. BMJ 2003;326:762. http://dx.doi.org/10.1136/bmj.326.7392.762/a
177. Ijäs H, Vääräsmäki M, Morin-Papunen L, Keravuo R, Ebeling T, Saarela T, Raudaskoski T. Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. BJOG 2011;118:880-5. http://dx.doi.org/10.1111/j.1471-0528.2010.02763.x
178. Mesdaghinia E, Samimi M, Homaei Z, Saberi F, Moosavi SG, Yaribakht M. Comparison of newborn outcomes in women with gestational diabetes mellitus treated with metformin or insulin: a randomised blinded trial. Int J Prev Med 2013;4:327-33.
179. Moore LE, Briery CM, Clokey D, Martin RW, Williford NJ, Bofill JA, Morrison JC. Metformin and insulin in the management of gestational diabetes mellitus: preliminary results of a comparison. J Reprod Med 2007;52:1011-15.
180. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP, MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008;358:2003-15. http://dx.doi.org/10.1056/NEJMoa0707193
181. Spaulonci CP, Bernardes LS, Trindade TC, Zugaib M, Francisco RP. Randomized trial of metformin vs insulin in the management of gestational diabetes. Am J Obstet Gynecol 2013;209:34.e1-7. http://dx.doi.org/10.1016/j.ajog.2013.03.022
182. Tertti K, Ekblad U, Koskinen P, Vahlberg T, Ronnemaa T. Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin. Diabetes Obes Metab 2013;15:246-51. http://dx.doi.org/10.1111/dom.12017
183. Zinnat ANS, Shareen S, Rahman S. Can metformin be used in place of insulin for the treatment of GDM for low resource countries? BJOG 2013;120:35.
184. Anjalakshi C, Balaji V, Balaji MS, Seshiah V. A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women. Diabetes Res Clin Pract 2007;76:474-5. http://dx.doi.org/10.1016/j.diabres.2006.09.031
185. Bertini AM, Silva JC, Taborda W, Becker F, Lemos Bebber FR, Zucco Viesi JM, et al. Perinatal outcomes and the use of oral hypoglycemic agents. J Perinat Med 2005;33:519-23. http://dx.doi.org/10.1515/JPM.2005.092
186. Lain KY, Garabedian MJ, Daftary A, Jeyabalan A. Neonatal adiposity following maternal treatment of gestational diabetes with glyburide compared with insulin. AmJ Obstet Gynecol 2009;200:501.e1-6. http://dx.doi.org/10.1016/j.ajog.2009.02.038
187. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343:1134-8. http://dx.doi.org/10.1056/NEJM200010193431601
188. Mukhopadhyay P, Bag TS, Kyal A, Saha DP, Khalid N. Oral hypoglycemic glibenclamide: can it be a substitute to insulin in the management of gestational diabetes mellitus? A comparative study. J South Asian Feder Obstet Gynae 2012;4:28-31. http://dx.doi.org/10.5005/jp-journals-10006-1167
189. Ogunyemi D, Jesse M, Davidson M. Comparison of glyburide versus insulin in management of gestational diabetes mellitus. Endocr Pract 2007;13:427-8. http://dx.doi.org/10.4158/EP.13.4.427
190. Silva JC, Bertini AM, Taborda W, Becker F, Bebber FR, Aquim GM, Viesi JM. [Glibenclamide in the treatment for gestational diabetes mellitus in a compared study to insulin.] Arq Bras Endocrinol Metabol 2007;51:541-6. http://dx.doi.org/10.1590/S0004-27302007000400007
191. Tempe A, Mayanglambam RD. Glyburide as treatment option for gestational diabetes mellitus. J Obstet Gynaecol Res 2013;39:1147-52. http://dx.doi.org/10.1111/jog.12042
192. Moore LE, Clokey D, Rappaport VJ, Curet LB. Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. Obstet Gynecol 2010;115:55-9. http://dx.doi.org/10.1097/AOG.0b013e3181c52132
193. Silva JC, Fachin DR, Coral ML, Bertini AM. Perinatal impact of the use of metformin and glyburide for the treatment of gestational diabetes mellitus. J Perinat Med 2012;40:225-8. http://dx.doi.org/10.1515/jpm-2011-0175
194. Abbassi-Ghanavati M, Casey B, Shivvers S, Tudela C, McIntire D, Leveno K. Randomized trial of glyburide plus diet compared to placebo plus diet in women with gestational diabetes Am J Obs Gynecol 2014;210:S179.
195. Balaji V, Balaji MS, Alexander C, Srinivasan A, Suganthi SR, Thiyagarajah A, Seshiah V. Premixed insulin aspart 30 (BIAsp 30) versus premixed human insulin 30 (BHI 30) in gestational diabetes mellitus: a randomized open-label controlled study. Gynecol Endocrinol 2012;28:529-32. http://dx.doi.org/10.3109/09513590.2011.650661
196. Niromanesh S, Alavi A, Sharbaf FR, Amjadi N, Moosavi S, Akbari S. Metformin compared with insulin in the management of gestational diabetes mellitus: a randomized clinical trial. Diabetes Res Clin Pract 2012;98:422-9. http://dx.doi.org/10.1016/j.diabres.2012.09.031
197. Deveer R, Deveer M, Akbaba E, Engin-Üstün Y, Aydogan P, Celikkaya H, et al. The effect of diet on pregnancy outcomes among pregnant with abnormal glucose challenge test. Eur Rev Med Pharmacol Sci 2013;17:1258-61.
198. Li DF, Wong VC, O’Hoy KM, Yeung CY, Ma HK. Is treatment needed for mild impairment of glucose tolerance in pregnancy? A randomized controlled trial. Br J Obstet Gynaecol 1987;94:851-4. http://dx.doi.org/10.1111/j.1471-0528.1987.tb03753.x
199. Yang X, Hsu-Hage B, Dong L, Shao P, Wang H, Tian H, et al. Intensive diabetes management may improve pregnancy: outcomes in Chinese gravidas with impaired glucose tolerance. Diabetes Care 2003;26:254-5. http://dx.doi.org/10.2337/diacare.26.1.254
200. Elnour AA, Mugammar IT, Jaber T, Revel T, McElnay JC. Pharmaceutical care of patients with gestational diabetes mellitus. J Eval Clin Prac 2008;14:131-40. http://dx.doi.org/10.1111/j.1365-2753.2007.00819.x
201. Garner P, Okun N, Keely E, Wells G, Perkins S, Sylvain J, Belcher J. A randomized controlled trial of strict glycemic control and tertiary level obstetric care versus routine obstetric care in the management of gestational diabetes: a pilot study. Am J Obstet Gynecol 1997;177:190-5. http://dx.doi.org/10.1016/S0002-9378(97)70461-7
202. Bevier WC, Fischer R, Jovanovic L. Treatment of women with an abnormal glucose challenge test (but a normal oral glucose tolerance test) decreases the prevalence of macrosomia. Am J Perinatol 1999;16:269-75. http://dx.doi.org/10.1055/s-2007-993871
203. Bonomo M, Corica D, Mion E, Gonçalves D, Motta G, Merati R, et al. Evaluating the therapeutic approach in pregnancies complicated by borderline glucose intolerance: a randomized clinical trial. Diabet Med 2005;22:1536-41. http://dx.doi.org/10.1111/j.1464-5491.2005.01690.x
204. Bung P, Artal R, Khodiguian N, Kjos S. Exercise in gestational diabetes. An optional therapeutic approach? Diabetes 1991;40(Suppl. 2):182-5. http://dx.doi.org/10.2337/diab.40.2.S182
205. Kjos SL, Schaefer-Graf U, Sardesi S, Peters RK, Buley A, Xiang AH, et al. A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care 2001;24:1904-10. http://dx.doi.org/10.2337/diacare.24.11.1904
206. Moreno-Castilla C, Hernandez M, Bergua M, Alvarez MC, Arce MA, Rodriguez K, et al. Low-carbohydrate diet for the treatment of gestational diabetes mellitus: a randomized controlled trial. Diabetes Care 2013;36:2233-8. http://dx.doi.org/10.2337/dc12-2714
207. Nachum Z, Ben-Shlomo I, Weiner E, Shalev E. Twice daily versus four times daily insulin dose regimens for diabetes in pregnancy: randomised controlled trial. BMJ 1999;319:1223-7. http://dx.doi.org/10.1136/bmj.319.7219.1223
208. Thompson DJ, Porter KB, Gunnells DJ, Wagner PC, Spinnato JA. Prophylactic insulin in the management of gestational diabetes. Obstet Gynecol 1990;75:960-4.
209. Cypryk K, Kaminska P, Kosinski M, Pertynska-Marczewska M, Lewinski A. A comparison of the effectiveness, tolerability and safety of high and low carbohydrate diets in women with gestational diabetes. Endokrynol Pol 2007;58:314-19.
210. Di Cianni G, Volpe L, Ghio A, Lencioni C, Cuccuru I, Benzi L, Del Prato S. Maternal metabolic control and perinatal outcome in women with gestational diabetes mellitus treated with lispro or aspart insulin: comparison with regular insulin. Diabetes Care 2007;30:e11. http://dx.doi.org/10.2337/dc06-2586
211. O’Sullivan JB, Gellis SS, Dandrow RV, Tenney BO. The potential diabetic and her treatment in pregnancy. Obstet Gynecol 1966;27:683-9.
212. Rae A, Bond D, Evans S, North F, Roberman B, Walters B. A randomised controlled trial of dietary energy restriction in the management of obese women with gestational diabetes. Aust N Z J Obstet Gynaecol 2000;40:416-22. http://dx.doi.org/10.1111/j.1479-828X.2000.tb01172.x
213. Silva JC, Pacheco C, Bizato J, de Souza BV, Ribeiro TE, Bertini AM. Metformin compared with glyburide for the management of gestational diabetes. Int J Gynaecol Obstet 2010;111:37-40. http://dx.doi.org/10.1016/j.ijgo.2010.04.028
214. Ardilouze J-L, Ménard J, Hivert M-F. Gestational diabetes mellitus: a randomized study comparing insulin therapy to a combination of half-maximal dosages of metformin and glyburide. Can J Diab 2014;38:S23. http://dx.doi.org/10.1016/j.jcjd.2014.07.064
215. Asemi Z, Samimi M, Tabassi Z, Esmaillzadeh A. The effect of DASH diet on pregnancy outcomes in gestational diabetes: a randomized controlled clinical trial. Eur J Clin Nutr 2014;68:490-5. http://dx.doi.org/10.1038/ejcn.2013.296
216. Bo S, Rosato R, Ciccone G, Canil S, Gambino R, Poala CB, et al. Simple lifestyle recommendations and the outcomes of gestational diabetes. A 2×2 factorial randomized trial. Diabetes Obes Metab 2014;16:1032-5. http://dx.doi.org/10.1111/dom.12289
217. Cao X, Wang Z, Yang C, Mo X, Xiu L, Li Y, Xiao H. Comprehensive intensive therapy for Chinese gestational diabetes benefits both newborns and mothers. Diabetes Technol Ther 2012;14:1002-7. http://dx.doi.org/10.1089/dia.2012.0142
218. Jovanovic L, Ilic S, Pettitt DJ, Hugo K, Gutierrez M, Bowsher RR, Bastyr EJ. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care 1999;22:1422-7. http://dx.doi.org/10.2337/diacare.22.9.1422
219. Louie JCY, Markovic TP, Perera N, Foote D, Petocz P, Ross GP, et al. A randomized controlled trial investigating the effects of a low-glycemic index diet on pregnancy outcomes in gestational diabetes mellitus. Diabetes Care 2011;34:2341-6. http://dx.doi.org/10.2337/dc11-0985
220. Bahado-Singh RO, Mele L, Landon MB, Ramin SM, Carpenter MW, Casey B, et al. Fetal male gender and the benefits of treatment of mild gestational diabetes mellitus. Am J Obstet Gynecol 2012;206:422.e1-5. http://dx.doi.org/10.1016/j.ajog.2012.03.015
221. Hatem M, Anthony F, Hogston P, Rowe DJ, Dennis KJ. Reference values for 75g oral glucose tolerance test in pregnancy. Br Med J 1988;296:676-8. http://dx.doi.org/10.1136/bmj.296.6623.676
222. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53. http://dx.doi.org/10.1002/SICI(1096-9136199807)15:7<539::AID-DIA668>3.0.CO;2-S
223. Gillman MW, Oakey H, Baghurst PA, Volkmer RE, Robinson JS, Crowther CA. Effect of treatment of gestational diabetes mellitus on obesity in the next generation. Diabetes Care 2010;33:964-8. http://dx.doi.org/10.2337/dc09-1810
224. Thangaratinam S, Rogozinska E, Jolly K, Glinkowski S, Roseboom T, Tomlinson JW, et al. Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence. BMJ 2012;344:e2088. http://dx.doi.org/10.1136/bmj.e2088
225. National Institute for Health and Care Excellence (NICE). Guide to the Methods of Technology Appraisal 2013. London: NICE; 2013.
226. Claxton K, Martin S, Soares M, Rice N, Spackman E, Hinde S, et al. Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. Health Technol Assess 2015;19 14. http://dx.doi.org/10.3310/hta19140
227. Van Leeuwen M, Louwerse MD, Opmeer BC, Limpens J, Serlie MJ, Reitsma JB, Mol BW. Glucose challenge test for detecting gestational diabetes mellitus: a systematic review. BJOG 2012;119:393-401. http://dx.doi.org/10.1111/j.1471-0528.2011.03254.x
228. Waugh NR, Shyangdan D, Taylor-Phillips S, Suri G, Hall B. Screening for type 2 diabetes: a short report for the National Screening Committee. Health Technol Assess 2013;17 35. http://dx.doi.org/10.3310/hta17350
229. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25:1862-8. http://dx.doi.org/10.2337/diacare.25.10.1862
230. Lawlor DA, Lichtenstein P, Långström N. Association of maternal diabetes mellitus in pregnancy with offspring adiposity into early adulthood: sibling study in a prospective cohort of 280,866 men from 248,293 families. Circulation 2011;123:258-65. http://dx.doi.org/10.1161/CIRCULATIONAHA.110.980169
231. Royston P. Multiple imputation of missing values. Stata J 2004;4:227-41.
232. Round JA, Jacklin P, Fraser RB, Hughes RG, Mugglestone MA, Holt RI. Screening for gestational diabetes mellitus: cost-utility of different screening strategies based on a woman’s individual risk of disease. Diabetologia 2011;54:256-63. http://dx.doi.org/10.1007/s00125-010-1881-y
233. McClean S, Farrar D, Kelly CA, Tuffnell DJ, Whitelaw DC. The importance of postpartum glucose tolerance testing after pregnancies complicated by gestational diabetes. Diabet Med 2010;27:650-4. http://dx.doi.org/10.1111/j.1464-5491.2010.03001.x
234. Ward R, Lennard-Jones HE, Scott EM. How good is the postpartum follow-up of women with gestational diabetes: are NICE clinical recommendations being adhered to? Diabetic Med 2015;32:177-8.
235. Holt RI, Goddard JR, Clarke P, Coleman MA. A postnatal fasting plasma glucose is useful in determining which women with gestational diabetes should undergo a postnatal oral glucose tolerance test. Diabet Med 2003;20:594-8. http://dx.doi.org/10.1046/j.1464-5491.2003.00974.x
236. Ratner RE, Diabetes Prevention Program Research. An update on the Diabetes Prevention Program. Endocr Pract 2006;12(Suppl. 1):20-4. http://dx.doi.org/10.4158/EP.12.S1.20
237. Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 2008;93:4774-9. http://dx.doi.org/10.1210/jc.2008-0772
238. Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, Hsu RT, et al. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ 2008;336:1180-5. http://dx.doi.org/10.1136/bmj.39545.585289.25
239. Aroda VR, Christophi CA, Edelstein SL, Zhang P, Herman WH, Barrett-Conner E, et al. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: The Diabetes Prevention Program Outcomes Study 10-Year Follow-Up. J Clin Endocrinol Metab 2015;100:1646-53. http://dx.doi.org/10.1210/jc.2014-3761
240. National Institute for Health and Care Excellence (NICE). Diabetes in Pregnancy: Management of Diabetes and Its Complications from Pre-conception to the Postnatal Period. National Collaborating Centre for Women’s & Children’s Health (NCC-WCH). London: NICE; 2008.
241. Kim C, Tabaei BP, Burke R, McEwen LN, Lash RW, Johnson SL, et al. Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus. Am J Public Health 2006;96:1643-8. http://dx.doi.org/10.2105/AJPH.2005.065722
242. Seshiah V, Balaji V, Balaji MS, Sekar A, Sanjeevi C, Green A. One step procedure for screening and diagnosis of gestational diabetes mellitus. Diabetes 2005;126:200.
243. National Institute for Health and Care Excellence (NICE). Hypertension in Pregnancy: The Management of Hypertensive Disorders during Pregnancy. London: National Collaborating Centre for Women’s & Children’s Health (NCC-WCH). London: NICE; 2010.
244. Werner EF, Pettker CM, Zuckerwise L, Reel M, Funai EF, Henderson J, Thung SF. Screening for gestational diabetes mellitus: are the criteria proposed by the international association of the Diabetes and Pregnancy Study Groups cost-effective? Diabetes Care 2012;35:529-35. http://dx.doi.org/10.2337/dc11-1643
245. Kind P, Hardman G, Macran S. UK Population Norms for EQ-5D. York: Centre for Health Economics, University of York; 1999.
246. Sullivan PW, Slejko JF, Sculpher MJ, Ghushchyan V. Catalogue of EQ-5D scores for the United Kingdom. Med Decis Making 2011;31:800-4. http://dx.doi.org/10.1177/0272989X11401031
247. Curtis L. Unit Costs of Health and Social Care 2013. Canterbury: PSSRU, University of Kent; 2013.
248. Joint Formulary Committee. British National Formulary (online). London: BMJ Group and Pharmaceutical Press; 2014. URL: www.medicinescomplete.com (accessed 19 November 2014).
249. Department of Health (DH). NHS Reference Costs 2005-2006. London: DH; 2006.
250. National Health Service England and Wales. Electronic Drug Tariff-July 2014. 2014. URL: www.ppa.org.uk/edt/July_2014/mindex.htm (accessed 19 November 2014).
251. Diabetes Prevention Program Research Group. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care 2012;35:723-30. http://dx.doi.org/10.2337/dc11-1468
252. Briggs A, Mark Sculpher M, Claxton K. Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press; 2006.
253. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making 1985;5:157-77. http://dx.doi.org/10.1177/0272989X8500500205
254. Briggs A, Sculpher M, Claxton K. Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press; 2006.
255. Office for National Statistics (ONS). Births in England and Wales, 2013-14. 2015. URL: www.ons.gov.uk/ons/dcp171778_371129pdf (accessed 3 September 2015).
256. Barry E, Roberts S, Finer S, Vijayaraghavan S, Greenhalgh T. Time to question the NHS diabetes prevention programme. BMJ 2015;351:h4717. http://dx.doi.org/10.1136/bmj.h4717
257. O’Sullivan JB, Mahan CM, Charles D, Dandrow RV. Screening criteria for high-risk gestational diabetic patients. Am J Obstet Gynecol 1973;116:895-900.
258. Cundy T, Ackermann E, Ryan EA. Gestational diabetes: new criteria may triple the prevalence but effect on outcomes is unclear. BMJ 2014;348:g1567. http://dx.doi.org/10.1136/bmj.g1567
259. Balaji V, Balaji MS, Alexander C, Ashalata S, Sheela Suganthi R, Suresh S, Seshiah V. Premixed insulin aspart 30 (Biasp 30) vs. premixed human insulin 30 (BHI 30) in gestational diabetes mellitus-a pilot study. J Assoc Physicians India 2010;58:99-101.
260. Department of Health (DH). National Reference Costs 2012-13. London: DH; 2013. URL: www.gov.uk/government/uploads/system/uploads/attachment_data/file/261154/nhs_reference:costs_2012-13_acc.pdf (accessed December 2014).